victoza glp 1 (Liraglutide) GLP-1 injection FDA Approves First Generic GLP-1

Enrollees must be in an eligible Part D plan and meet one of three body mass index thresholds paired with specific clinical conditions, CMS confirmed

[DOI] [PubMed] [Google Scholar] 52.Chu Q, et al

Peak weight loss effects are generally observed between 6072 weeks of continuous treatment

www.cdc.gov/cancer/dataviz, released in June 2021

But doctors may need to consider recommending exercise programs or develop other approaches, such as nutrition supplements or complementary medications, to help GLP-1 patients get the full cardiorespiratory benefits of substantial weight loss over the long-run, the researchers say

Eligibility for the new program hinges on your BMI and whether you have a related condition like prediabetes, heart disease, or high blood pressure